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ABSTRACT We investigated a family of horses exhibiting irregular vertical stripes in their hair coat
texture along the neck, back, hindquarters, and upper legs. This phenotype is termed “brindle” by
horse breeders. We propose the term “brindle 1 (BR1)” for this specific form of brindle. In some BR1
horses, the stripes were also differentially pigmented. Pedigree analyses were suggestive of a mono-
genic X-chromosomal semidominant mode of inheritance. Haplotype analyses identified a 5 Mb can-
didate region on chromosome X. Whole genome sequencing of four BR1 and 60 nonbrindle horses
identified 61 private variants in the critical interval, none of them located in an exon of an annotated
gene. However, one of the private variants was close to an exon/intron boundary in intron 10 of the
MBTPS2 gene encoding the membrane bound transcription factor peptidase, site 2 (c.1437+4T.C).
Different coding variants in this gene lead to three related genodermatoses in human patients. We
therefore analyzed MBTPS2 transcripts in skin, and identified an aberrant transcript in a BR1 horse,
which lacked the entire exon 10 and parts of exon 11. The MBTPS2:c1437+4T.C variant showed
perfect cosegregation with the brindle phenotype in the investigated family, and was absent from
457 control horses of diverse breeds. Altogether, our genetic data, and previous knowledge on
MBTPS2 function in the skin, suggest that the identified MBTPS2 intronic variant leads to partial exon
skipping, and causes the BR1 phenotype in horses.
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In heterozygous females, X-linked skin conditions frequently result in a
characteristic patterning of the skin, following the so-called lines of
Blaschko (Happle 2006; Molho-Pessach and Schaffer 2011; Happle
2016). The Blaschko lines describe stripes of affected skin follow specific
patterns along lines of the body. These lines, S-shaped on the side of the
body, and V-shaped on the back, follow the trajectory of cell migration
and proliferation during embryogenesis. These characteristic patterns are
the result of X-chromosome inactivation (also called lyonization). In het-
erozygous females, the lesions are restricted to skin areas that derive from
cell clones, inwhich thewild-typeX-chromosomehas become inactivated,
and only the mutant X-chromosome is expressed. X-chromosome inac-
tivation thus leads to functionalmosaicism, and explains different patterns
that do not correspond to the nervous, muscular, or lymphatic system
(Happle 2006; Sun and Tsao 2008). Examples of human X-linked geno-
dermatoses showing this phenomenon are incontinentia pigmenti, focal
dermal hypoplasia, and hypohidrotic ectodermal dysplasia (Smahi et al.
2000; Grzeschik et al. 2007; X. Wang et al. 2007; Kere et al. 1996).
Copyright © 2016 Murgiano et al.
doi: 10.1534/g3.116.032433
Manuscript received June 13, 2016; accepted for publication July 20, 2016;
published Early Online July 22, 2016.
This is an open-access article distributed under the terms of the Creative
Commons Attribution 4.0 International License (http://creativecommons.org/
licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction
in any medium, provided the original work is properly cited.
Supplemental material is available online at www.g3journal.org/lookup/suppl/
doi:10.1534/g3.116.032433/-/DC1
1Corresponding author: Institute of Genetics, Vetsuisse Faculty, University of Bern,
3001 Switzerland. E-mail: tosso.leeb@vetsuisse.unibe.ch
Volume 6 | September 2016 | 2963
The investigation of spontaneous domestic animal mutants display-
ing skin phenotypes can yield new insights into the functions of genes
during epidermal development or in the regulation of skin homeostasis
(Drögemüller et al. 2008, 2014; Jagannathan et al. 2013).We previously
reported X-linked skin conditions that lead to striped patterns, includ-
ing the streaked hairlessness in Italian Pezzata Rossa cattle, which is
caused by a TSR2 splice site variant (Murgiano et al. 2015), and incon-
tinentia pigmenti in horses, which is caused by an IKBKG nonsense
variant (Towers et al. 2013). Horses with incontinentia pigmenti dis-
play pruritic, exudative skin lesions soon after birth. These develop into
wart-like lesions and areas of alopecia. Affected horses also have streaks
of darker and lighter coat coloration from birth. These cutaneous man-
ifestations in horses with incontinentia pigmenti follow the lines of
Blaschko (Towers et al. 2013). In the horse family segregating for
incontinentia pigmenti, an independent, but closely related phenotype
with a striped coat texture pattern has long been recognized by
breeders, and is termed brindle. The term brindle has been used for
similar phenotypes in different breeds, and may in fact refer to horses
with different genetic alterations, including rare spontaneous chi-
meras (Sponenberg 2009). Due to the ambiguities associated with
the term brindle, we will use the term brindle 1 (BR1) for the specific
brindle pattern observed in the investigated family.
In contrast to horseswith incontinentia pigmenti, BR1 horses donot
showanyhoofor teethabnormalities.Theaimof thepresentstudywas to
characterize the genetics underlying the BR1phenotype. As this phenotype
has never been fully described in the scientific literature, we also present a
preliminary qualitative characterization of the BR1 phenotype.
MATERIALS AND METHODS
Samples and phenotypes
Three experienced breeders submitted hair or EDTA blood samples
from 39 closely related horses segregating for both incontinentia pig-
menti (Towers et al. 2013) and the BR1 phenotype for this study. Most
of these horses had an American Quarter Horse or American Paint
Horse registration, but some were also registered as warmblood horses.
The phenotype classification into BR1 and control horses was based on
the breeders’ reports.
We additionally used samples from 457 unrelated horses from
diverse breeds not suspected to have the BR1 phenotype, which had
been collected in the course of other projects at the Institute of Genetics
of the University of Bern.We isolated genomic DNA from hair roots or
EDTA blood samples according to standard procedures.
Hair samples and hair morphology analyses
One breeder submitted hairs of lesional andnonlesional areas from four
female BR1 horses (UKH11, UKH15, UKH21, and UKH23) in sepa-
rately labeled bags for macroscopic and microscopic examination.
Nonlesional was defined as hair from the base colored, or normal
textured, coat and “lesional” was defined as hair from the phenotypi-
cally different coat stripes (abnormal texture and striping as seen in
Figure 1 and Figure 2). Samples were coded by one investigator (P. R.).
Another investigator (P. B.) analyzed the macroscopic andmicroscopic
appearance without knowing whether they came from lesional or non-
lesional areas. The following parameters were quantitatively assessed in
three hairs from each sample: length of the hairs, surface area of the
roots, diameter of the hair shafts at four different positions (25% of
shaft length, 50% of shaft length, 75% of shaft length, tip of the hair,
where the medulla ends), and diameter of the root. Student’s t-tests
with a significance threshold of P = 0.05 were performed for statistical
analysis. In addition to the quantitative parameters, the curvature of the
hairs shafts was also assessed qualitatively.
Skin biopsies and histopathological examination
Two 6 mmpunch biopsies were obtained from the skin of a BR1 horse
(UKH04) after local anesthesia with 2% lidocaine. The biopsies were
collected from the lesional streaks and fromnormal (nonlesional) areas.
Figure 1 Hair coat phenotype of BR1 horses. Vertical
stripes and irregular coat are macroscopically visible in
the (A) winter and (B) summer coat of the same BR1
mare (UKH23). (C) The stallion UKH38 born out of a BR1
mare did not show the pronounced striped pattern, but
had a very sparse mane and tail.
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Biopsies were fixed in 4% buffered formalin, processed routinely, and
stained with hematoxylin and eosin prior to histopathological exami-
nation. Two further biopsies from comparable sites on the same horse
were submerged in RNAlater solution for subsequent RNA isolation.
Genotyping
Genotyping of 22 BR1 and 14 control horses was performed by
Geneseek/Neogen using the illumina Equine SNP70 chip containing
73,774 evenly distributed SNPs.
Haplotype reconstruction
We used LINKPHASE3 (Druet and Georges 2015) to reconstruct hap-
lotypes in the genotyped pedigree based onMendelian segregation rules
and linkage information. Detailed information on the methodology
andmodifications required to analyze the X-chromosome are described
in Supplemental Material, File S1.
Whole genome resequencing, SNP and short
indel calling
We prepared PCR-free genomic fragment libraries with 350 bp insert
size and collected roughly 20· coverage data on an IlluminaHiSeq2500
or HiSeq3000 instrument (2 · 100, 2 · 125, or 2 · 150 bp). Se-
quence reads were mapped to the horse reference genome, and aligned
using Burrows-Wheeler Aligner (BWA) version 0.5.9-r16 (Li and
Durbin 2009) with default settings. The SAM file generated by BWA
was then converted to BAM, and the reads sorted by chromosome
using samtools (Li 2011). PCR duplicates were marked using Picard
tools (http://sourceforge.net/projects/picard/). We used the Ge-
nome Analysis Tool Kit (GATK version 2.4.9, 50) to perform local
realignment, and to produce a cleaned BAM file. Variant calls were
then made with the Unified Genotyper module of GATK (McKenna
et al. 2010). The variant data for each sample was obtained in variant
call format (version 4.0) as raw calls for all samples, and sites flagged
using the variant filtration module of GATK. Variant filtration was
performed, following best practice documentation of GATK version
4. The snpEFF software (Cingolani et al. 2012) together with the
EquCab 2.0 annotation was used to predict the functional effects of
detected variants.
Structural variant calling
We used the Delly package (Rausch et al. 2012) to look for larger
deletions in the sequenced family trio, using daughter and mother as
case and the father as control. Delly uses paired-ends and split-reads
to sensitively and accurately delineate genomic rearrangements
throughout the genome. Delly was run four times; each time, the
command line contained either the DEL, DUP, INV, or TRA com-
mand after the –t command that specifies the request to look for
deletions, tandem duplications, inversions, and translocations,
respectively.
To identify whether copy number variation was associated with the
BR1 phenotype, we used the software PennCNV (K.Wang et al. 2007).
PennCNV uses a hidden Markov model based approach that takes
into account signal intensity, allelic intensity ratio, distance between
markers, and allele frequency to call CNVs. We built the input consist-
ing into the PFB file, the intensity file and GCModel file from the data
obtained from themanufacturer, using 22 animals present in one single
SNP batch.
Sanger sequencing
The associated MBTPS2 variant was genotyped by resequencing of
targeted PCR products (forward-primer: GCTACTCCAATTTTC
AAGCGT, reverse-primer: TCCCTGCCACATCTTAACCT) using
Sanger sequencing technology. PCR products were amplified with
AmpliTaqGold360Mastermix (Life Technologies), and the products
directly sequenced using the PCR primers on an ABI 3730 capillary
sequencer (Life Technologies) after treatment with exonuclease I and
shrimp alkaline phosphatase. Sequence data were analyzed using
Sequencher 5.1 (GeneCodes).
In silico splice site analysis
We used the “Splice-Site Analyzer Tool”, for a computational analysis
of the strength of the wildtype and mutant 59-splice sites of the equine
MBTPS2 gene. This program is freely available on the internet (http://
ibis.tau.ac.il/ssat/SpliceSiteFrame.htm), and analyzes the free energy for
the binding of the primary transcript to the U1 RNA of the spliceo-
some. The program is based on a dataset of 50,493 homologous
human-mouse internal exons (Carmel et al. 2004).
RT-PCR
The RNA was extracted from skin tissues using the RNeasy mini kit
(Qiagen). The tissuewasfirst finely crushed inTRIZOL (Ambion) using
mechanical means, chloroform was then added and the RNA was
separated by centrifugation. The RNA was cleared of genomic DNA
contaminationusing theQuantitectReverseTranscriptionKit (Qiagen).
The same kit was used to synthetize cDNA, as described by the manu-
facturer. An RT-PCR was carried out using primer MBTPS2_Ex8_F,
Figure 2 Pigmentation phenotype of BR1 mares. (A)
Pronounced alternating stripes of eumelanin and pheo-
melanin in a horse with solid coat color (UKH14). (B) The
horse UKH11 had the frame overo spotting phenotype
caused by the EDNRB:c.354_355delinsAG variant,
and a bay base color. This horse showed fine lines of
pigmented skin in areas that would be devoid of mela-
nocytes and pigmentation in nonbrindle horses with
the frame-overo spotting pattern. (C) The BR1 mare
UKH004 showed only a very subtle pattern of striped
pigmentation on her coat. (D) The same mare UKH004
showed a much more pronounced pattern of irregular
pigmentation in her skin after clipping the hair. These
photos illustrate different types of streaky pigmentation
seen in some BR1 horses.
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ACAAACGGCTAGATGGTTCG, located in exon 8 and primer
MBTPS2_Ex11_R, ATCCACTGTCCATCCAAAGC, located in
exon 11 of the MBTPS2 gene. The products were analyzed on a
Fragment Analyzer capillary gel electrophoresis instrument (Ad-
vanced Analytical). To estimate the proportion of the aberrant
MBTPS2 transcript, we divided the peak area of the smallerMBTPS2
band by the sum of the peak areas of both MBTPS2 bands. The
sequence of the obtained PCR product was confirmed by Sanger
sequencing as described above. All numbering within the equine
MBTPS2 gene was done with respect to the reference transcript,
GenBank accession XM_005614038.2.
Data availability
Figure S1 shows the Sanger sequence data of MBTPS2 transcripts.
File S1 describes the detailed methodology for the haplotype
analyses. Table S1 gives the gene annotation of the BR1 critical
interval on the X chromosome as taken from NCBI MapViewer
and the EquCab 2 assembly. Table S2 contains the complete
list of 61 BR1-associated genetic variants in the critical interval.
Table S3 provides a list of the numbers and breeds of the 457 con-
trol horses used for the genetic association study. The whole ge-
nome sequencing data from 64 horses were deposited with the
European Nucleotide Archive. The accession numbers are listed
in Table S4.
RESULTS
Qualitative phenotype description
We previously reported a family of horses segregating incontinentia
pigmenti characterized by consecutive characteristic stages (cutaneous
pruritic, exudative lesions at birth, later on wart-like lesions, and
additional tooth, hoof, and ocular anomalies; Towers et al. 2013). In
the same horse family, breeders observed a milder phenotype that is
restricted to an irregular striped texture and color pattern of the hair
coat (Figure 1). The stripes generally formed a vertical pattern from the
back to the sides of the animal. Breeders termed this phenotype “brin-
dle” and we suggest brindle 1 or BR1 for this specific form of brindle.
The observed BR1 phenotypes are quite variable in intensity between
horses, and the phenotype also changes with season (summer vs.winter
hair coat). The winter coat of BR1 horses often adopted a “moth eaten”
appearance (Figure 1A). Some BR1 horses had sparse mane and tail
hair. The BR1 phenotype occurred in horses with different base coat
colors. In addition to the coat structure changes, some brindle horses
also displayed vertical stripes of different pigmentation (Figure 2).
Macroscopic examination of the hairs revealed that hairs from the
streaks were less straight, or were unruly, compared to the hairs from
the normally pigmented and textured coat (Figure 3). No consistent
difference in hair length, pigmentation, or diameter could be observed
between the investigated lesional and nonlesional samples. On micro-
scopic evaluation, we did not find any significant differences between
the lesional and nonlesional hairs.
A histopathological examination in one brindle mare did not detect
any difference between lesional and nonlesional skin areas. As expected
at the end of winter, the vast majority of hair follicles were in telogen,
or early anagen, and no difference concerning the pigmentation or
morphology of the hair shafts, or the differentiation of hair follicles, was
histologically evident between biopsies taken from two different
locations.
An X-linked mechanism of inheritance
All BR1 horses investigated during this study are descendants of a single
Quarter Horse mare UKH22, born in 1985. We compiled a pedigree of
the horses sampled for this study (Figure 4).Most notably, all daughters
Figure 4 Family tree of BR1 horses. Males are represented by squares, females by circles. Animals showing the BR1 phenotype are indicated with
filled black symbols. Affected males do not show the striped coat texture pattern, but they have a sparse mane and tail. Symbols filled in half with
green color indicate mares affected by incontinentia pigmenti, which was confirmed by genotyping the IKBKG:c.C.T variant. Arrows indicate the
animals for which whole genome sequences were produced. The mare UKH22, born in 1985, represents the putative founder of the BR1
phenotype.
Figure 3 Macroscopic hair phenotype. The hairs from the lesional
stripes (A) are more unruly compared to hairs from a nonlesional area
of the same BR1 horse (B). Hairs were sampled during winter.
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of the stallion UKH09 were reported to exhibit the BR1 phenotype,
whereas all of his sons produced by matings with wildtype mares were
normal. This stallion did not show the typical striped pattern of the hair
coat, but had a sparse mane and tail. Based on the pedigree and
the phenotype of the stallion UKH09, we hypothesized that BR1 is
inherited as amonogenic X-chromosomal semidominant trait. Accord-
ing to this hypothesis, the “typical” BR1 phenotype with a striped coat
texture pattern can only be seen in heterozygous females, whereas
hemizygous mutant males and homozygous mutant females will pri-
marily show a sparse mane and tail, but no stripes.
Mapping of a candidate region
To localize the BR1 gene, we genotyped 36 horses from the sampled
family on the equine illumina 70 k SNP chip. We reconstructed the
haplotypes in the genotyped family and searched for the presence of
shared haplotypes among the BR1 horses. The likelihood of a shared
haplotype among the BR1 horses was null for all marker positions
except for a 5 Mb segment on chromosome X spanning from posi-
tions 13,601,933 to 18,711,357 (EquCab2 assembly; markers BIEC2-
1111129 - BIEC2-1112988). Only for that segment, the likelihood of a
shared haplotype was higher than 0.99. Thus the haplotype analysis
confirmed our hypothesis of an X-linked mode of inheritance. There
were 41 annotated genes in the critical interval (Table S1).
Identification of the causative variant
Wesequenced thegenomesof a trioconsistingof aBR1female (UKH16)
together with her BR1 mother (UKH11), and her nonaffected father
(UKH029), as well as one additional BR1 horse (UKH04). From our
previous project on incontinentia pigmenti, we additionally had the
genome sequence of an incontinentia pigmenti horse from the same
family, which also carried the BR1 haplotype (UKH03). Finally, we had
whole genome sequence data from 59 additional horses from diverse
breeds not suspected to have the BR1 phenotype, which had been
obtained previously in the course of other projects. Thus, we had four
female genomes predicted to be heterozygous at the BR1 locus, and
60 control genomes,which shouldbe eitherhemizygous orhomozygous
wildtype at the causative variant. Together, these 64 horse genomes
comprised . 62 million genetic variants.
Filtering for high-confidence heterozygous single nucleotide and
small indel variants, private to the four BR1 cases, yielded 61 such
variants in the critical interval on the X-chromosome. None of these
61 variants were located in an exon of an annotated gene (Table S2). A
search for structural variants using the programs Delly and PennCNV
did not identify any such variants in the critical interval.
Visual inspection of the 61 candidate variants for their potential
functional relevance led us to focus our attention on a single nucleotide
variant g.16,391,590T.C, which was located at position +4 of in-
tron 10 of theMBTPS2 gene (c.1437+4T.C). We confirmed the pres-
ence of this variant by Sanger sequencing (Figure 5).
Genetic association of the MBTPS2:c.1437+4T>C variant
We genotyped the 39 available horses from the investigated family, and
found perfect cosegregation of the variant with the BR1 phenotype. In
this family, we observed14nonaffectedhorses, whichwere homozygous
or hemizygous for the wildtype allele.We had 21 heterozygous females;
19 of these heterozygous females showed the BR1 phenotype, and, in
the remaining two, the BR1 phenotype could not be seen due to the
simultaneous presence of the more severe incontinentia pigmenti
phenotype. Finally, we had four hemizygous mutant males with sparse
mane and tail.
We further genotyped 457 control horses from17 genetically diverse
horse and pony breeds for the MBTPS2:c.1437+4T.C variant (Table
S3). The mutant allele did not occur in any of these horses.
An MBTPS2 splice defect
Due to its position next to an exon/intron boundary, we hypothesized
that theMBTPS2:c.1437+4T.C variant might have a potential impact
on the correct splicing of MBTPS2 transcripts, and thereby cause the
phenotype. An in silico analysis of the wildtype (CAAgtatcc) and mu-
tant (CAAgtaccc) 59-splice site sequences of intron 10 predicted a
slightly reduced score for the binding of the mutant 59-splice site to
the U1 RNA of the spliceosome. Both sequences represented relatively
weak 59-splice sites.
We performed an RT-PCR to experimentally test the consequences
of the 59-splice site variant. Primers located in exons 8 and 11 of the
MBTPS2 gene were used to amplify cDNA from the skin of a BR1 horse
and an unrelated control. The BR1 horse expressed the wildtype tran-
script, but also a transcript that lacked 96 nucleotides (nt) consisting of
the entire exon 10 and the first 20 nt of exon 11, confirming the
existence of an aberrantly splicedMBTPS2 transcript in the BR1 horse
(Figure 6 and Figure S1). The identity of the RT-PCR bands was con-
firmed by direct Sanger sequencing. The proportion of the mutant
transcript in the BR1 horse was roughly 20%, and we observed
Figure 5 Genomic context of the MBTPS2:c.1437+4T.C variant. (A)
The 5 Mb haplotype on the X-chromosome, which was shared by all
BR1 horses, is shown in light blue. The MBTPS2 genomic organization
and the position of the variant are indicated (exons and introns are not
drawn to scale). (B) Screenshot of the illumina sequence reads of a
brindle mare indicating the presence of a heterozygous T.C variant.
(C) Sanger electropherograms of a homozygous wildtype female, a
heterozygous female, and a hemizygous mutant male.
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a minimally higher proportion of mutant transcript in the skin biopsy
taken from a lesional skin area compared to the skin biopsy taken from
a nonlesional skin area. However, as we had only two biopsies from one
horse for this analysis, it is unclear whether this difference is significant.
The mutant transcript contained an open reading frame lacking 32
codons, which encode parts of the third luminal and the entire sixth
transmembrane domain of the MBTPS2 protein (p.422_453del).
DISCUSSION
In this study,weprovideaninitialandqualitativephenotypicdescription
of one form of brindle in horses, termed “brindle 1 (BR1)”. This form of
brindle is phenotypically quite variable, and some horses are predom-
inantly characterized by coat texture changes, while, in others, the
striped pigmentation pattern is the predominant feature. More com-
prehensive quantitative morphometric studies will be needed to fully
characterize all changes in hair structure and pigmentation that can
occur in BR1 horses. It will also be interesting to see whether hemi-
zygous mutant males and homozygous mutant females will show some
subtle alteration of their body hair in addition to their sparse manes
and tails.
Wemapped the causative locus for this formof brindle in horses to a
5 Mb segment on the X-chromosome. A whole genome sequencing
approach identified a single nucleotide variant within the 59-splice site
of intron 10 of theMBTPS2 gene. We have to caution that the equine
reference genome assembly and annotation are not perfect, which im-
pedes our variant detection sensitivity. For example, the horse genome
reference contains two gap regions within the equine MBTPS2 gene,
one of them harboring exon 9, with 196 coding nt. Thus we cannot
exclude the possibility that we missed one or several additional genetic
variants in linkage disequilibrium with the 61 identified private vari-
ants. However, we can at least rule out exon 9 of theMBTPS2 gene, as
this exon was unchanged in the cDNA Sanger sequencing data from a
BR1 horse.
TheMBTPS2:c.1437+4T.C variant cosegregated perfectly with the
phenotype in an extended horse family, and was absent from a large
cohort of horses from diverse breeds. We further confirmed the expres-
sion of an additional aberrantly splicedMBTPS2 transcript in the skin
of a BR1 horse.
The MBTPS2 gene encodes the membrane bound transcription
factor peptidase, site 2, a zinc metalloprotease located in the membrane
of the endoplasmic reticulum (ER) and Golgi apparatus. MBTPS2
cleaves sterol regulatory element binding proteins (SREBPs) within a
transmembrane segment, releasing the amino-terminal domain of the
SREBP from themembrane so that it can enter the nucleus and activate
target genes encoding e.g., the low density lipoprotein receptor and
enzymes for cholesterol and fatty acid biosynthesis (Rawson et al.
1997; Zelenski et al. 1999; Kroos and Akiyama 2013).
Genetic variants in MBTPS2 lead to three related genodermatoses
in human patients: ichthyosis follicularis, atrichia, and photophobia
(IFAP, OMIM #308205, Oeffner et al. 2009), Olmsted syndrome/
palmoplantar keratoderma (OLMSX, OMIM #300918, Haghighi et al.
2013), and keratosis follicularis spinulosa decalvans (KFSDX, OMIM
#308800, Aten et al. 2010). A detailed genotype–phenotype correla-
tion for a large number of different human variants has been pub-
lished (Bornholdt et al. 2013). It is thought that the complete absence
of functional MBTPS2 is lethal. Depending on the specific genetic
variant, male human patients carrying missense mutations in the
MBTPS2 gene show mostly quite severe phenotypes, sometimes with
additional developmental aberrations and/or mental retardation in
addition to the skin changes termed BRESEK/BRESHECK syndrome
(Reish et al. 1997). Females carrying any of theseMBTPS2 gene variants
in heterozygous state show skin changes of varying severity that follow
the lines of Blaschko, or no visible phenotype at all. Male human IFAP
patients with intronicMBTPS2 variants affecting splicing were report-
ed. Unfortunately, RNA of these patients was not available, and it is
therefore unknown which proportions of wildtype and aberrant tran-
scripts were expressed (Oeffner et al. 2011).
It is not fully elucidated how MBTPS2 deficiency mechanistically
causes the observed skin and hair changes in human patients.MBTPS2
deficiency is thought to lead to changes in ER stress response and sterol
homeostasis, including cholesterol biosynthesis. Several other defects in
genes required for steroid and lipid metabolism are also associated with
genodermatoses, such as, e.g., ichthyoses (Feingold and Elias 2014).
Based on the fact that hair morphology is altered in both BR1 horses
and human patients with MBTPS2 variants, we propose that the ob-
served splice defect is actually causative for the BR1 phenotype in
horses. The BR1 phenotype is clearly much milder than the different
phenotypes reported in human patients with codingMBTPS2 variants.
We speculate that this might be due to the specific equine variant and
Figure 6 Experimental verification of the MBTPS2 splice defect. (A)
The MBTPS2 transcript is shown. On the enlarged 39-end of the tran-
script, the position of the primers used for RT-PCR is indicated. (B)
RT-PCR was performed using skin RNA from a brindle and a control
horse. The picture shows a Fragment Analyzer gel image of the ex-
periment. In the control animal (wt), only the expected 439 bp band is
visible. For the brindle horse, two RNA samples from lesional (L) and
nonlesional (NL) skin were used. In both samples, an additional
343 bp band corresponding to a transcript lacking the entire exon 10
and parts of exon 11 can be seen. The variant designation on the
transcript level thus is r.[=,1265_1360del]. The band at the bottom
of all three lanes with RT-PCR products corresponds to molecules
of , 50 nt in size, and probably consists of residual unused primers
or primer dimers. The aberrant 343 bp band comprised 23% and 19%
of the total transcripts in the lesional and nonlesional skin sample,
respectively.
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the high proportion of wildtype transcript, which is still expressed in
the skin of mutant horses. It remains to be investigated whether the
predicted truncated MBTPS2 protein is actually expressed and cor-
rectly localized in BR1 horses. In this case, it could potentially exert a
dominant-negative function in cells that express both wildtype and
mutant protein (gain of function). On the other hand, it is also possible
that the truncated protein is not correctly processed, and is rapidly
degraded. In this case, BR1 horses might be lacking sufficient amounts
of functional MBTPS2 protein to maintain a completely normal coat
appearance (loss of function).
The obtained data do not definitively prove the causality of the
MBTPS2:c.1437+4T.C variant for the BR1 phenotype. However, in
our opinion, our genetic association data together with the experimen-
tal confirmation of altered MBTPS2 splicing and the previous knowl-
edge on the biological function of MBTPS2 in skin, provide very strong
suggestive evidence thatMBTPS2:c.1437+4T.C does indeed cause the
skin and hair coat changes seen in BR1 horses.
In summary, we provided evidence that BR1 in horses is inherited as
an X-chromosomal semidominant trait. A positional cloning approach
identified the intronic variant c.1437+4T.C and a resulting splice
defect in the MBTPS2 gene as candidate causative mechanism under-
lying the BR1 phenotype.
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